These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2824368)

  • 1. Regulation of Na+, K+-ATPase by the endogenous sodium transport inhibitor from hypothalamus.
    Haupert GT
    Hypertension; 1987 Nov; 10(5 Pt 2):I61-6. PubMed ID: 2824368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic factor inhibits the (Na,K)ATPase from the extracellular surface. Mechanism of inhibition.
    Carilli CT; Berne M; Cantley LC; Haupert GT
    J Biol Chem; 1985 Jan; 260(2):1027-31. PubMed ID: 2981828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Na+ pump in renal tubular cells is regulated by endogenous Na+-K+-ATPase inhibitor from hypothalamus.
    Cantiello HF; Chen E; Ray S; Haupert GT
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F574-80. PubMed ID: 2845805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic sodium-transport inhibitor is a high-affinity reversible inhibitor of Na+-K+-ATPase.
    Haupert GT; Carilli CT; Cantley LC
    Am J Physiol; 1984 Dec; 247(6 Pt 2):F919-24. PubMed ID: 6095682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Na,K-ATPase of cultured bovine lens epithelial cells: H2O2 effects.
    Garner MH; Bahador A; Thi Nguyen BT; Wang RR; Spector A
    Exp Eye Res; 1992 Mar; 54(3):321-8. PubMed ID: 1325918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The search for a hypothalamic Na+,K+-ATPase inhibitor.
    Haber E; Haupert GT
    Hypertension; 1987 Apr; 9(4):315-24. PubMed ID: 2435655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of monoclonal antibody-induced alterations in Na+/K+-ATPase conformations using fluorescein-labeled enzyme.
    Friedman ML; Ball WJ
    Biochim Biophys Acta; 1989 Mar; 995(1):42-53. PubMed ID: 2466488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of cooperating alpha subunits in working (Na+ + K+)-ATPase by the use of the MgATP complex analogue cobalt tetrammine ATP.
    Scheiner-Bobis G; Fahlbusch K; Schoner W
    Eur J Biochem; 1987 Oct; 168(1):123-31. PubMed ID: 2822400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimethyl sulfoxide inhibits renal Na(+)-K(+)-ATPase at a site different from ouabain and atrial peptides.
    Chiou S; Vesely DL
    Life Sci; 1995; 57(10):945-55. PubMed ID: 7643719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Na,K-ATPase polypeptide upregulation responses in lens epithelium.
    Delamere NA; Manning RE; Liu L; Moseley AE; Dean WL
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):763-8. PubMed ID: 9538883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II directly stimulates activity and alters the phosphorylation of Na-K-ATPase in rat proximal tubule with a rapid time course.
    Yingst DR; Massey KJ; Rossi NF; Mohanty MJ; Mattingly RR
    Am J Physiol Renal Physiol; 2004 Oct; 287(4):F713-21. PubMed ID: 15161602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of protein kinase C, (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues.
    Zheng B; Oishi K; Shoji M; Eibl H; Berdel WE; Hajdu J; Vogler WR; Kuo JF
    Cancer Res; 1990 May; 50(10):3025-31. PubMed ID: 2159369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic Na(+)-K(+)-ATPase inhibitor characterized in two-sided liposomes containing pure renal Na(+)-K(+)-ATPase.
    Anner BM; Rey HG; Moosmayer M; Meszoely I; Haupert GT
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F144-53. PubMed ID: 2154124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for tryptophan residues in the cation transport path of the Na(+),K(+)-ATPase.
    Yudowski GA; Bar Shimon M; Tal DM; González-Lebrero RM; Rossi RC; Garrahan PJ; Beaugé LA; Karlish SJ
    Biochemistry; 2003 Sep; 42(34):10212-22. PubMed ID: 12939149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells.
    Liu J; Periyasamy SM; Gunning W; Fedorova OV; Bagrov AY; Malhotra D; Xie Z; Shapiro JI
    Kidney Int; 2002 Dec; 62(6):2118-25. PubMed ID: 12427136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking of Na+/K+ transport by the MgPO4 complex analogue Co(NH3)4PO4 leaves the Na+/Na(+)-exchange reaction of the sodium pump unaltered and shifts its high-affinity ATP-binding site to a Na(+)-like form.
    Buxbaum E; Schoner W
    Eur J Biochem; 1990 Oct; 193(2):355-60. PubMed ID: 1699757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituting manganese for magnesium alters certain reaction properties of the (Na+ + K+)-ATPase.
    Robinson JD
    Biochim Biophys Acta; 1981 Apr; 642(2):405-17. PubMed ID: 6269615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependency of renal potassium excretion on Na,K-ATPase transport rate.
    Sejersted OM; Monclair T; Mathisen O; Hartmann A; Kiil F
    Acta Physiol Scand; 1985 Jan; 123(1):9-19. PubMed ID: 2982247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus.
    Hallaq HA; Haupert GT
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10080-4. PubMed ID: 2557617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphate binding and ATP-binding sites coexist in Na+/K(+)-transporting ATPase, as demonstrated by the inactivating MgPO4 complex analogue Co(NH3)4PO4.
    Buxbaum E; Schoner W
    Eur J Biochem; 1991 Jan; 195(2):407-19. PubMed ID: 1847680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.